The calendar of French medical cannabis experimentation is slowly sliding towards the start of the new academic year in 2020, or even later, as predicted.
During the first hearings of the Fact-Finding Mission on Cannabis, Christelle Ratignier-Carbonneil, Deputy Director-General of the ANSM, explains that :
the objective is that the experimentation will be ready for patients at the beginning of the academic year 2020″, “in September.
Not indicating whether in September, the 3000 patients will already have access to medical cannabis or whether this will only be the beginning of their inclusion in the experimentation of medical cannabis, further delaying the deadlines.
The CST “implementation of medical cannabis experimentation in France” is currently meeting to define both the method of distribution of products, the way to secure prescriptions besides the products that will be offered.
The official distributors should be selected by the end of February. So , if it had been rumored that the ANSM was leaning towards donations of cannabis to provide the experimentation. It would seem that this is not an official obligation according to the ANSM’s FAQ.
Cannabis research, on the other hand, is open, with the possibility of conducting clinical studies in parallel with the experiment.
Moreover , it now remains for the Committee to set up the prescription and distribution circuit, identify eligible patients and train health professionals. Concerning access to cannabis, the discussions would focus not on the distribution that is not database but on players who offer to take part in it. Is all this achievable in 9 months, including two summers?
Although the strikes have not made it easier to hold CST meetings, French patients are currently waiting for a legal solution.